Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis

Zachary M. Soler, J. Madison Hyer, Luke Rudmik, Viswanathan Ramakrishnan, Timothy Smith, Rodney J. Schlosser

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: Current clinical classifications of chronic rhinosinusitis (CRS) have weak prognostic utility regarding treatment outcomes. Simplified discriminant analysis based on unsupervised clustering has identified novel phenotypic subgroups of CRS, but prognostic utility is unknown. Objective: We sought to determine whether discriminant analysis allows prognostication in patients choosing surgery versus continued medical management. Methods: A multi-institutional prospective study of patients with CRS in whom initial medical therapy failed who then self-selected continued medical management or surgical treatment was used to separate patients into 5 clusters based on a previously described discriminant analysis using total Sino-Nasal Outcome Test-22 (SNOT-22) score, age, and missed productivity. Patients completed the SNOT-22 at baseline and for 18 months of follow-up. Baseline demographic and objective measures included olfactory testing, computed tomography, and endoscopy scoring. SNOT-22 outcomes for surgical versus continued medical treatment were compared across clusters. Results: Data were available on 690 patients. Baseline differences in demographics, comorbidities, objective disease measures, and patient-reported outcomes were similar to previous clustering reports. Three of 5 clusters identified by means of discriminant analysis had improved SNOT-22 outcomes with surgical intervention when compared with continued medical management (surgery was a mean of 21.2 points better across these 3 clusters at 6 months, P <.05). These differences were sustained at 18 months of follow-up. Two of 5 clusters had similar outcomes when comparing surgery with continued medical management. Conclusion: A simplified discriminant analysis based on 3 common clinical variables is able to cluster patients and provide prognostic information regarding surgical treatment versus continued medical management in patients with CRS.

Original languageEnglish (US)
JournalJournal of Allergy and Clinical Immunology
DOIs
StateAccepted/In press - Jun 23 2015

Fingerprint

Cluster Analysis
Discriminant Analysis
Nose
Demography
Therapeutics
Endoscopy
Comorbidity
Tomography
Prospective Studies

Keywords

  • Chronic rhinosinusitis
  • Cluster
  • Outcomes
  • Prediction
  • Quality of life
  • Sinusitis
  • Treatment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis. / Soler, Zachary M.; Hyer, J. Madison; Rudmik, Luke; Ramakrishnan, Viswanathan; Smith, Timothy; Schlosser, Rodney J.

In: Journal of Allergy and Clinical Immunology, 23.06.2015.

Research output: Contribution to journalArticle

Soler, Zachary M. ; Hyer, J. Madison ; Rudmik, Luke ; Ramakrishnan, Viswanathan ; Smith, Timothy ; Schlosser, Rodney J. / Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis. In: Journal of Allergy and Clinical Immunology. 2015.
@article{99733d9308fa4eeca6190a13a08b8492,
title = "Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis",
abstract = "Background: Current clinical classifications of chronic rhinosinusitis (CRS) have weak prognostic utility regarding treatment outcomes. Simplified discriminant analysis based on unsupervised clustering has identified novel phenotypic subgroups of CRS, but prognostic utility is unknown. Objective: We sought to determine whether discriminant analysis allows prognostication in patients choosing surgery versus continued medical management. Methods: A multi-institutional prospective study of patients with CRS in whom initial medical therapy failed who then self-selected continued medical management or surgical treatment was used to separate patients into 5 clusters based on a previously described discriminant analysis using total Sino-Nasal Outcome Test-22 (SNOT-22) score, age, and missed productivity. Patients completed the SNOT-22 at baseline and for 18 months of follow-up. Baseline demographic and objective measures included olfactory testing, computed tomography, and endoscopy scoring. SNOT-22 outcomes for surgical versus continued medical treatment were compared across clusters. Results: Data were available on 690 patients. Baseline differences in demographics, comorbidities, objective disease measures, and patient-reported outcomes were similar to previous clustering reports. Three of 5 clusters identified by means of discriminant analysis had improved SNOT-22 outcomes with surgical intervention when compared with continued medical management (surgery was a mean of 21.2 points better across these 3 clusters at 6 months, P <.05). These differences were sustained at 18 months of follow-up. Two of 5 clusters had similar outcomes when comparing surgery with continued medical management. Conclusion: A simplified discriminant analysis based on 3 common clinical variables is able to cluster patients and provide prognostic information regarding surgical treatment versus continued medical management in patients with CRS.",
keywords = "Chronic rhinosinusitis, Cluster, Outcomes, Prediction, Quality of life, Sinusitis, Treatment",
author = "Soler, {Zachary M.} and Hyer, {J. Madison} and Luke Rudmik and Viswanathan Ramakrishnan and Timothy Smith and Schlosser, {Rodney J.}",
year = "2015",
month = "6",
day = "23",
doi = "10.1016/j.jaci.2015.11.019",
language = "English (US)",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis

AU - Soler, Zachary M.

AU - Hyer, J. Madison

AU - Rudmik, Luke

AU - Ramakrishnan, Viswanathan

AU - Smith, Timothy

AU - Schlosser, Rodney J.

PY - 2015/6/23

Y1 - 2015/6/23

N2 - Background: Current clinical classifications of chronic rhinosinusitis (CRS) have weak prognostic utility regarding treatment outcomes. Simplified discriminant analysis based on unsupervised clustering has identified novel phenotypic subgroups of CRS, but prognostic utility is unknown. Objective: We sought to determine whether discriminant analysis allows prognostication in patients choosing surgery versus continued medical management. Methods: A multi-institutional prospective study of patients with CRS in whom initial medical therapy failed who then self-selected continued medical management or surgical treatment was used to separate patients into 5 clusters based on a previously described discriminant analysis using total Sino-Nasal Outcome Test-22 (SNOT-22) score, age, and missed productivity. Patients completed the SNOT-22 at baseline and for 18 months of follow-up. Baseline demographic and objective measures included olfactory testing, computed tomography, and endoscopy scoring. SNOT-22 outcomes for surgical versus continued medical treatment were compared across clusters. Results: Data were available on 690 patients. Baseline differences in demographics, comorbidities, objective disease measures, and patient-reported outcomes were similar to previous clustering reports. Three of 5 clusters identified by means of discriminant analysis had improved SNOT-22 outcomes with surgical intervention when compared with continued medical management (surgery was a mean of 21.2 points better across these 3 clusters at 6 months, P <.05). These differences were sustained at 18 months of follow-up. Two of 5 clusters had similar outcomes when comparing surgery with continued medical management. Conclusion: A simplified discriminant analysis based on 3 common clinical variables is able to cluster patients and provide prognostic information regarding surgical treatment versus continued medical management in patients with CRS.

AB - Background: Current clinical classifications of chronic rhinosinusitis (CRS) have weak prognostic utility regarding treatment outcomes. Simplified discriminant analysis based on unsupervised clustering has identified novel phenotypic subgroups of CRS, but prognostic utility is unknown. Objective: We sought to determine whether discriminant analysis allows prognostication in patients choosing surgery versus continued medical management. Methods: A multi-institutional prospective study of patients with CRS in whom initial medical therapy failed who then self-selected continued medical management or surgical treatment was used to separate patients into 5 clusters based on a previously described discriminant analysis using total Sino-Nasal Outcome Test-22 (SNOT-22) score, age, and missed productivity. Patients completed the SNOT-22 at baseline and for 18 months of follow-up. Baseline demographic and objective measures included olfactory testing, computed tomography, and endoscopy scoring. SNOT-22 outcomes for surgical versus continued medical treatment were compared across clusters. Results: Data were available on 690 patients. Baseline differences in demographics, comorbidities, objective disease measures, and patient-reported outcomes were similar to previous clustering reports. Three of 5 clusters identified by means of discriminant analysis had improved SNOT-22 outcomes with surgical intervention when compared with continued medical management (surgery was a mean of 21.2 points better across these 3 clusters at 6 months, P <.05). These differences were sustained at 18 months of follow-up. Two of 5 clusters had similar outcomes when comparing surgery with continued medical management. Conclusion: A simplified discriminant analysis based on 3 common clinical variables is able to cluster patients and provide prognostic information regarding surgical treatment versus continued medical management in patients with CRS.

KW - Chronic rhinosinusitis

KW - Cluster

KW - Outcomes

KW - Prediction

KW - Quality of life

KW - Sinusitis

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84956946785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956946785&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2015.11.019

DO - 10.1016/j.jaci.2015.11.019

M3 - Article

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

ER -